Insights Into Participating in Studies for Bone Cancer
Not yet recruiting
- Conditions
- Bone Cancer
- Registration Number
- NCT06070259
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical studies, with a distinct focus on bone cancer, play a crucial role in evaluating the safety and effectiveness of novel treatments for this disease. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption.
The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- Diagnosis of bone cancer
- No prior treatment for bone cancer
Read More
Exclusion Criteria
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- Enrolled in another research study
- Inability to provide written informed consent
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who decide to enroll in a bone cancer clinical research. 3 months Number of bone cancer study participants who remain in clinical study until completion. 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States